Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
379.02 USD | +0.08% |
|
+1.76% | +26.28% |
06-23 | HCA Healthcare Positioned to Withstand Policy Shifts Through Resiliency Program, RBC Says | MT |
06-23 | RBC Raises Price Target on HCA Healthcare to $404 From $376, Keeps Outperform Rating | MT |
Capitalization | 91.18B 78.41B 73.35B 66.92B 125B 7,838B 140B 868B 334B 3,611B 342B 335B 13,198B | P/E ratio 2025 * |
15x | P/E ratio 2026 * | 13.5x |
---|---|---|---|---|---|
Enterprise value | 136B 117B 109B 99.67B 186B 11,674B 209B 1,293B 497B 5,379B 509B 499B 19,657B | EV / Sales 2025 * |
1.82x | EV / Sales 2026 * | 1.74x |
Free-Float |
71.58% | Yield 2025 * |
0.75% | Yield 2026 * | 0.77% |
More valuation ratios
* Estimated data
More news
Last Transcript: HCA Healthcare, Inc.
More recommendations
More press releases
More news
1 day | +0.08% | ||
1 week | +1.76% | ||
Current month | -0.62% | ||
1 month | +0.65% | ||
3 months | +13.53% | ||
6 months | +24.42% | ||
Current year | +26.28% |
1 week | 372.33 | ![]() | 380.64 |
1 month | 350.74 | ![]() | 386.56 |
Current year | 289.98 | ![]() | 388.38 |
1 year | 289.98 | ![]() | 417.14 |
3 years | 164.47 | ![]() | 417.14 |
5 years | 91.44 | ![]() | 417.14 |
10 years | 43.91 | ![]() | 417.14 |
Manager | Title | Age | Since |
---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 63 | 31/12/2018 |
Mike Marks
DFI | Director of Finance/CFO | 55 | 30/04/2024 |
Randy Fagin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director | Title | Age | Since |
---|---|---|---|
Thomas Frist
CHM | Chairman | 57 | 25/04/2019 |
William Frist
BRD | Director/Board Member | 55 | 31/12/2008 |
Samuel Hazen
BRD | Director/Board Member | 63 | 09/09/2018 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
1.96% | 6 M€ | 0.00% | - | |
1.88% | 21 M€ | +1.83% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.08% | +1.76% | +11.03% | +107.88% | 91.11B | ||
+1.15% | +0.73% | +9.48% | -28.50% | 84.52B | ||
+1.17% | -1.74% | +48.96% | +50.39% | 27.15B | ||
+5.66% | +8.16% | -8.87% | +35.20% | 23.39B | ||
+0.57% | +1.19% | +26.22% | +8.23% | 21.85B | ||
+0.10% | +0.53% | +28.29% | +28.22% | 20.06B | ||
+2.05% | +0.97% | +31.33% | +1.38% | 15.84B | ||
+1.42% | +2.42% | +26.09% | +194.51% | 15.71B | ||
+1.96% | -0.31% | +32.96% | +19.53% | 13.93B | ||
+0.44% | -2.26% | +33.31% | +222.00% | 13.39B | ||
Average | +1.33% | -0.19% | +23.88% | +63.88% | 32.7B | |
Weighted average by Cap. | +1.07% | +0.45% | +17.98% | +51.01% |
2025 * | 2026 * | |
---|---|---|
Net sales | 74.73B 64.26B 60.12B 54.84B 102B 6,424B 115B 712B 273B 2,960B 280B 274B 10,817B | 78.5B 67.5B 63.15B 57.61B 108B 6,747B 121B 747B 287B 3,109B 294B 288B 11,361B |
Net income | 6.18B 5.31B 4.97B 4.53B 8.46B 531B 9.49B 58.81B 22.6B 245B 23.17B 22.68B 894B | 6.48B 5.57B 5.21B 4.76B 8.88B 557B 9.96B 61.71B 23.71B 257B 24.31B 23.8B 938B |
Net Debt | 44.63B 38.38B 35.9B 32.75B 61.15B 3,836B 68.55B 425B 163B 1,768B 167B 164B 6,460B | 45.45B 39.08B 36.56B 33.35B 62.27B 3,907B 69.81B 433B 166B 1,800B 171B 167B 6,578B |
More financial data
* Estimated data
Employees
271,000
Calendar
Date | Price | Change | Volume |
---|---|---|---|
24/06/25 | 379.02 $ | +0.08% | 1,105,073 |
23/06/25 | 378.72 $ | +0.32% | 1,098,033 |
20/06/25 | 377.50 $ | +0.17% | 4,238,388 |
18/06/25 | 376.86 $ | +1.18% | 1,374,261 |
17/06/25 | 372.45 $ | +1.05% | 1,334,129 |
Delayed Quote Nyse, June 24, 2025 at 09:00 pm
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
379.02USD
Average target price
387.75USD
Spread / Average Target
+2.30%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition